Research in development
At DACRIN, our mission is to facilitate AOD clinical research in NSW. To achieve this, we conduct independent research and collaborate with external organisations. We welcome fresh ideas and initiatives from drug and alcohol health professionals, both members and non-members of DACRIN. Furthermore, we appreciate the input of people with lived experience. Visit
collaborate with DACRIN to find out more.
Here are some of our upcoming research projects and partnerships:
| DACRIN 2025-8: A Phase II study of medicinal cannabis products in the treatment of chronic pain in patients with opioid dependence | DACRIN (SESLHD) |
| DACRIN 2025-7: Increasing engagement in opioid dependence treatment (ODT) to prevent overdose following release from custody. | DACRIN (SLHD) |
| DACRIN 2025-6: Telehealth-delivered step-down for alcohol and other drug withdrawal | DACRIN (SVHN) |
| DACRIN 2025-5: Implementation of integrated addiction medicine clinics for alcohol-associated liver disease | DACRIN (SLHD) |
DACRIN 2025-4: Preventing opioid overdose death by distribution of take-home naloxone (THN) after non-fatal overdose
| DACRIN (SESLHD) |
| DACRIN 2025-3: Incentivising Hepatitis C Virus (HCV) treatment engagement in Drug & Alcohol services: Financial Incentives for Direct Acting Antivirals (FIDAA) | DACRIN (HNELHD) |